medicine, the components of which have been well investigated, and magnolol, honokiol and obovatol are well known. Magnolol has been known to have many biological activities such as anti-platelet aggregation, 3) hydroxyl radical scavenging, 4) Ca 2ϩ -channel blocking 5) and anti-inflammatory action. 6) Our previous studies demonstrated anti-tumor effects of magnolol, particularly the inhibition of tumor cell invasion, 7) metastasis 8) and angiogenesis. 9) In addition, in a spontaneous lung metastasis model using B16-BL6 melanoma, multiple intraperitoneal administration of 10 mg/kg of magnolol after tumor inoculation significantly suppressed lung metastasis and primary tumor growth. 8) We previously reported that daily intraperitoneal injections of magnolol suppressed tumor growth by the subcutaneous inoculation of B16-BL6, and then inhibited the neovascularization. We have tried to evaluate the inhibitory mechanism of tumor growth caused by the administration of magnolol. In the present study, we investigated the ability of magnolol to induce apoptosis in the tumor cells treated, and its relation to the activation of caspase-3 and caspase-8. Chemical Reagents Magnolol was kindly provided by Dr. T. Asao and Dr. T. Terada of Taiho Pharmaceutical Co., Ltd. (Hanno, Japan). The substrate for caspase-3, acetyl-AspGlu-Val-Asp-4-metyl-coumaryl-7-amide (DEVD-MCA), the substrate for cleaving enzyme of procaspase 3 (Caspase-8/-6 and granzyme B), acetyl-Ile-Glu-Thr-Asp-4-Metyl-coumaryl-7-amide (IETD-MCA) and Val-Ala-Asp(Ome)-CH 2 F (z-VAD-fmk) as a inhibitor for all caspases were purchased from Peptide Institute (Osaka, Japan).
MATERIALS AND METHODS

Cells and Culture
Cell Proliferation Assay Various concentrations of magnolol were added to 1ϫ10 4 HT-1080 fibrosarcoma, B16-BL6 melanoma, THP-1 leukemia or BAE cells suspended in the culture medium supplemented with 10% FBS, in 9 cm dish. The culture was incubated at 37°C for various time in a 5% CO 2 atmosphere. Number of viable cells was counted by trypan-blue dye exclusion.
Analysis of DNA Fragmentation Cells (1ϫ10 6 ) were collected and washed with cold phosphate-buffered saline (PBS) after they were treated with magnolol for 24 h. The cell were resuspended with PBS, and lysed in a lysis buffer (10% polyethylene glycol mono-p-isooctylphenyl ether, 0.5 M ethylenediamine tetraacetic acid (EDTA) and 1 M Tris-HCl buffer, pH 7.4) at 4°C for 10 min. The lysate was centrifuged at 15000 g for 20 min, and the supernatant was incubated with RNase, and then with proteinase K, both at 37°C for 60 min. Then, DNA was extracted with isopropanol-5 M NaCl (6 : 1, vol : vol). The purified DNA was dissolved in TE buffer (1 M Tris-HCl buffer, pH 7.4 and 0.5 M EDTA) and was separated electrophoretically on 2% agarose gel at 75 V for 100 min and stained with ethidium bromide. The bands of DNA fragments were visualized under UV light and photographed.
Caspase Fluorogenic Activity Assay Caspases activities were assayed according to the method of Mizukami et al. 10) Human fibrosarcoma HT-1080 (1ϫ10 6 ) were treated with magnolol for 24 h, then collected and washed with PBS. The cells were lysed (25 mM Hepes, 5 mM MgCl 2 , 5 mM EDTA, 1 mM ethylene glycol bis-(2-aminoethylether) N,N,NЈ,NЈ-tetraacetic acid, containing 1 mM phenylmethylsulfonyl fluoride and 5 mM dithiothreitol) and centrifuged at 60000 g for 20 min. The protein concentration of the supernatant was determined using Bio-rad reagent (Bio-rad, California, U.S.A.). This lysate was incubated at 37°C with DEVD-MCA or IETD-MCA. The total volume of the reaction mixture was 50 ml. After incubation for 1 h, 2 ml of 1 M acetic acid was added to the reaction mixture and the fluorescence intensity was measured. Excitation and emission wavelengths are 380 nm and 460 nm, respectively.
Statistical Analysis The statistical significance of differences between groups was calculated by student's two-tailed t-test. pϽ0.05 was considered significant.
RESULTS
Cytotoxic Activity of Magnolol towards Various Cell
Lines To determine the cytotoxic activity of magnolol by trypan-blue dye exclusion assay, we used mouse melanoma B16-BL6, human fibrosarcoma HT-1080, human acute monocytic leukemia THP-1 and BAE cells. Magnolol at 100 mM inhibited the growth of the four cells lines, which were not affected up to 10 mM of magnolol for 24 h (Fig. 2) . Magnolol at 30 mM did not affected the growth of THP-1 and BAE cells (Fig. 2) .
Induction of Apoptosis by Magnolol in Various Cell Lines
To investigate whether the inhibitory effects on tumor growth in vivo and in vitro are caused by apoptosis, cell morphology of magnolol-treated or non-treated human fibrosarcoma HT-1080 was observed under a microscope at a magnification of ϫ200. HT-1080 cells treated with magnolol at 100 mM for 18 h and 24 h showed typical morphological characteristics of apoptosis, such as swelling-shape (Fig. 3) . These changes were not observed at 30 mM. Furthermore, magnolol-induced apoptosis was confirmed by observation of DNA fragmentation after 24 h treatment with magnolol at 100 mM (Fig. 4) . DNA fragmentation was observed, and only magnolol at 100 mM exhibited the apoptotic changes in HT-1080, B16-BL6 and THP-1 cells. However, BAE cells treated with 100 mM of magnolol did not show apoptotic morphological changes (Fig. 3) and the formation of typical DNA ladder (Fig. 4) .
Activation of Caspases in Magnolol-Induced Apoptosis
To investigate the involvement of caspases in magnolol-induced apoptosis, we examined caspase activity in magnololtreated cells by measurement of the fluorescence released by the cleavage of the caspase substrate: DEVD-MCA or IETD-MCA. When the caspase-3 and caspase-8 activities in human fibrosarcoma HT-1080 treated with magnolol were measured at time course, the activation of caspase-3 and caspase-8 was observed later than 18 h after magnolol treatment (Fig. 5) . In addition, the apoptotic DNA fragmentation by magnolol at 100 mM was inhibited by the pre-treatment of caspases inhibitor, z-VAD-fmk (Fig. 6 ).
DISCUSSION
We previously reported that magnolol showed the regression of tumor growth caused by subcutaneous injections of B16-BL6 melanoma cells into the right hind footpad.
8) The anti-tumor ability of magnolol was so strong that we suspected its contribution to the apoptosis induction. To clarify the mechanism of tumor growth inhibition by the administration of magnolol, we investigated the apoptosis induction ability of magnolol in the tumor cells. We demonstrated that magnolol induced apoptotic cell death, and inhibited cells growth in vitro. We previously reported that the co-injection of magnolol at 30 mM and the tumor cell significantly suppressed angiogenesis and tumor growth.
9) The magnolol concentration at which co-injection of magnolol suppressed tumor growth was lower than the concentration that inhibited the tumor cell proliferation and induced the apoptosis. These HT-1080 cells were treated z-VAD-fmk (25 mM) for 6 h, and then added to magnolol at 100 mM. After incubation for 24 h, treated cells were collected and DNA fragmentation was detected on 2% agarose gel electrophoresis. Lane 1ϭz-VAD-fmk only, 2ϭcontrol, 3ϭz-VAD-fmkϩmagnolol, 4ϭmagnolol only.
results suggest that the anti-tumor effect of magnolol is also associated with both of apoptotic induction and anti-angiogenic activity.
We also demonstrated that the HT-1080 cells treated with magnolol at 100 mM showed the typical morphological characteristics of apoptosis and led to DNA fragmentation. Furthermore, the activation of caspase-3 and caspase-8 was observed later than 18 h after magnolol treatment. Because the times of activation of caspase and formation of DNA fragmentation are almost coincide, it is suggested that the magnolol induces caspase-3 and caspase-8 dependent apoptosis. In addition, magnolol-induced apoptosis was blocked by the caspases inhibitor. However, we could not confirm the route of apoptosis from these data, and further investigation is needed. Magnolol has many biological activities such as hydroxyl radical scavenging, 4) Ca 2ϩ -channel blocking 5) and cytosolic free Ca 2ϩ -elevation inducing.
11) Calcium entry into cells appears to be a critical early event in apoptosis.
12) The endonuclease that causes characteristic apoptotic cleavage of chromatin is calcium dependent. 13) McConkey et al. reported that increase of calcium triggered to stimulate glucocorticoid and T cell receptor in thymocytes and cell death was prevented by blocking of the calcium increase. 14, 15) Moreover, Vignaux reported an importance of extracellular Ca 2ϩ and intracellular Ca 2ϩ for Fas-mediated apoptotic cell death. 16, 17) Activated Fas receptor recruits Fas-associated death domain protein (FADD), and this leads to proteolytic activation of the caspase-8 and caspase-3. These reports may support our conclusion that magnolol may induce apoptosis through Fas-mediated death pathway. Indeed, we observed the activation of caspase-3 and caspase-8 after magnolol treatment. Magnolol is contained in the bark of Magnolia obovata, which has been used in Chinese traditional medicine for the relief of fever, headache, anxiety and stroke. Though data are not shown, i.p. injection of magnolol at 100 mg/kg to mice did not show any toxicity to mice in the blood test, such as serum aspartate transaminase, serum alanine transaminase, serum total bilirubin, and total protein. Magnolol is expected to be harmless enough to have no serious side effect.
Our study found that magnolol induced apoptotic cell death with the activation of caspase, and suppressed tumor cells growth in vitro. The inhibitory mechanisms of magnolol on tumor growth were due to not only anti-angiogenic action but also apoptotic induction. Therefore, magnolol has both of anti-tumor activity and anti-metastatic activities, and may be used as a powerful tool for clinical cancer therapy.
